Cancer
-
Kidney Cancer Research Highlights from ASCO 2022 Annual Meeting
. Updated Yasser Ged,1 and Nirmish Singla2,* 1) Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA…
Read More » -
Engineered T-Cell Therapy: The Next Direction for RCC Immuno-oncology?
JJ H. Zhang, MD,1 Neal A. Patel, MD,1 Alexandra Drakaki, MD, PhD,1,2 Allan J. Pantuck, MD1,* 1) Institute of Urologic Oncology, Department of…
Read More » -
Comparison of Papillary Renal Cell Carcinoma Type 1 and Type 2: A Secondary Data Analysis
Melissa Paquin, PhD,1 Tracy Fasolino, PhD, FNP,2 Joe Bible, PhD,3 Mary Beth Steck, PhD,2 Joel Williams, PhD.4 1. Clemson University, Hampton, GA 30228 USA.…
Read More » -
Recent Advances in Tivozanib plus Nivolumab Combinatorial Strategies in Renal Cell Carcinoma
Robert J Motzer, MD 1, Toni K Choueiri, MD 2, Laurence Albiges, MD, PhD 3,Robert A. Figlin, MD, FACP4 Memorial…
Read More » -
Rcwd Sendinblue for Gravity Forms Nulled Free Download
Rcwd Sendinblue for Gravity Forms Nulled Free Download DOWNLOAD Rcwd Sendinblue for Gravity Forms Technical Data Developer RCWD Version WordPress…
Read More » -
From Gene Discovery to a FDA approval; Belzutifan’s Fascinating Journey at UTSW
Published on: August 21, 2021 A novel kidney cancer drug developed from UT Southwestern Medical Center received approval from the Food…
Read More » -
Keytruda plus Lenvima Combo Received FDA Approval for Advanced Kidney Cancer
August 20, 2021 Frontline Keytruda plus Lenvima for advanced renal cell carcinoma is an effective treatment with life-prolonging benefits, although…
Read More » -
Combo of cabozantinib plus atezolizumab active across kidney cancer subtypes
September 9, 2021 By Gregor Kreth Recent findings based on the phase 1b COSMIC-021 trial in Journal of Clinical Oncology…
Read More » -
US FDA Approves Belzutifan for Tumors Associated With Certain Types of Von Hippel-Lindau Disease
By Gregor Kreth, Guest Writer August 16, 2021 FDA approves Merck’s Welireg for the treatment of adult patients with von…
Read More » -
Medical Disclaimer
– The contents of the GUcancers Site, such as text, graphics, images, and other material contained on the GUcancers Site…
Read More »
